Could Positive Results on a COVID Anitbody Drug Be Just What the Markets Need?

<p>Markets were under pressure Tuesday on renewed fears about the spread of the coronavirus, but could late-breaking news out of a Regeneron trial turn things around?</p><p>Plus, after-hours earning action in shares of Micron, and will it be a happy holiday season for retailers?</p>